These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1438807)

  • 1. Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.
    Berger MR; Yanapirut P; Reinhardt M; Klenner T; Scherf HR; Schmeiser HH; Eibl H
    Prog Exp Tumor Res; 1992; 34():98-115. PubMed ID: 1438807
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
    Kötting J; Berger MR; Unger C; Eibl H
    Cancer Chemother Pharmacol; 1992; 30(2):105-12. PubMed ID: 1600590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P; Berger MR; Unger C; Eibl H
    Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
    [No Abstract]   [Full Text] [Related]  

  • 4. Hexadecylphosphocholine differs from conventional cytostatic agents.
    Berger MR; Betsch B; Gebelein M; Amtmann E; Heyl P; Scherf HR
    J Cancer Res Clin Oncol; 1993; 119(9):541-8. PubMed ID: 8392075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
    Yanapirut P; Berger MR; Reinhardt M; Schmähl D
    Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP; Fischer AH; Jordan VC
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978
    [No Abstract]   [Full Text] [Related]  

  • 7. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C; Berger MR; Schuler B; Scherf HR; Garzon FT; Zeller WJ; Unger C; Eibl HJ; Schmähl D
    Lipids; 1987 Nov; 22(11):930-4. PubMed ID: 3444388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.
    Berger MR; Munder PG; Schmähl D; Westphal O
    Oncology; 1984; 41(2):109-13. PubMed ID: 6538675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma.
    Klenner T; Berger MR; Eisenbrand G; Schmähl D
    Br J Cancer; 1989 Mar; 59(3):335-40. PubMed ID: 2930696
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations.
    Zeisig R; Fichtner I; Arndt D; Jungmann S
    Anticancer Drugs; 1991 Aug; 2(4):411-7. PubMed ID: 1797199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexadecylphosphocholine: a new and selective antitumor drug.
    Eibl H; Unger C
    Cancer Treat Rev; 1990 Sep; 17(2-3):233-42. PubMed ID: 2272038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P; Drevs J; Berger MR; Kötting J; Marschner N; Unger C; Eibl H
    Cancer Chemother Pharmacol; 1994; 34(5):393-8. PubMed ID: 8070005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat--benefit of combining bisphosphonates with cytostatic agents.
    Wingen F; Pool BL; Klein P; Klenner T; Schmähl D
    Invest New Drugs; 1988 Sep; 6(3):155-67. PubMed ID: 3056867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
    Reinhardt M; Heyl P; Amelung F; Berger MR
    Arzneimittelforschung; 1992 Oct; 42(10):1239-42. PubMed ID: 1282010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice.
    Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G
    J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
    Petru E; Berger MR; Zeller WJ; Kaufmann M
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor heterogeneity and chemosensitivity to cyclophosphamide, vinblastine and hexadecylphosphocholine.
    Angres G; Scherf HR; Schmähl D
    Cancer Treat Rev; 1990 Sep; 17(2-3):339-45. PubMed ID: 2272049
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chemically induced autochthonous rat mammary and colorectal carcinomas with interleukin-2.
    Berger MR; Salas M; Garzon F; Petru E; Schwulera U; Schmähl D
    Cancer Immunol Immunother; 1991; 33(5):346-9. PubMed ID: 1868493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma.
    Brix HP; Berger MR; Schneider MR; Tang WC; Eisenbrand G
    J Cancer Res Clin Oncol; 1990; 116(6):538-49. PubMed ID: 2254372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo.
    Sobottka SB; Berger MR; Eibl H
    Int J Cancer; 1993 Feb; 53(3):418-25. PubMed ID: 8428795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.